Novel therapies in CIDP Devan Mair, Heba Madi, Filip Eftimov, Michael P Lunn, Stephen Keddie
16 December 2024
C5 complement inhibition versus FcRn modulation in generalised myasthenia gravis Niklas Huntemann, Lea Gerischer, Meret Herdick, Christopher Nelke, Frauke Stascheit, Sarah Hoffmann, Menekse Öztürk, Christina B Schroeter, Sophie Lehnerer, Maike Stein, Charlotte Schubert, Christiane Schneider-Gold, Steffen Pfeuffer, Heidrun H Krämer, Franz Felix KonenSee the full list of authors
24 March 2025
Pain and functional neurological disorder: a systematic review and meta-analysis Moritz Steinruecke, Isabel Mason, Mairi Keen, Laura McWhirter, Alan J Carson, Jon Stone, Ingrid Hoeritzauer
16 August 2024
Neuropathy with anti-myelin-associated glycoprotein antibodies: update on diagnosis, pathophysiology and management Young Gi Min, Andrea Visentin, Chiara Briani, Yusuf A Rajabally
24 March 2025
Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse Benjamin P Trewin, Russell C Dale, Jessica Qiu, Melissa Chu, Niroshan Jeyakumar, Fionna Dela Cruz, Jane Andersen, Pakeeran Siriratnam, Kit Kwan M Ma, Todd A Hardy, Anneke van der Walt, Jeanette Lechner-Scott, Helmut Butzkueven, Simon A Broadley, Michael H BarnettSee the full list of authors
16 October 2024
Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies Pietro Emiliano Doneddu, Dario Cocito, Raffaella Fazio, Luana Benedetti, Erdita Peci, Giuseppe Liberatore, Yuri Matteo Falzone, Francesco Germano, Francesca Gallia, Claudia Giannotta, Cinta Lleixà, Elisa Bianchi, Eduardo Nobile-Orazio
16 August 2024
Vestibular neurology for the generalist Mohammad Mahmud, Diego Kaski
18 November 2024
Incidence and prevalence of functional neurological disorder: a systematic review Sara A Finkelstein, Clare Diamond, Alan Carson, Jon Stone
24 March 2025
Head trauma results in manyfold increased risk of multiple sclerosis in genetically susceptible individuals Eva Johansson, Lars Alfredsson, Pernilla Strid, Ingrid Kockum, Tomas Olsson, Anna Karin Hedström
14 May 2024
NICE guideline on ME/CFS: robust advice based on a thorough review of the evidence Peter Walter Barry, Kate Kelley, Toni Tan, Ilora Finlay
17 June 2024
Induction cyclophosphamide with maintenance immunosuppression in high-risk myasthenia gravis: long-term follow-up and safety profile Fiona Chan, Todd A Hardy, Sameer Malik, Sudarshini Ramanathan, D Sean Riminton, Stephen W Reddel
18 November 2024
Genetics of inherited peripheral neuropathies and the next frontier: looking backwards to progress forwards Jevin M Parmar, Nigel G Laing, Marina L Kennerson, Gianina Ravenscroft
16 October 2024
Poor long-term outcomes and abnormal neurodegeneration biomarkers after military traumatic brain injury: the ADVANCE study Neil SN Graham, Grace Blissitt, Karl Zimmerman, Lydia Orton, Daniel Friedland, Emma Coady, Rhiannon Laban, Elena Veleva, Amanda J Heslegrave, Henrik Zetterberg, Susie Schofield, Nicola T Fear, Christopher J Boos, Anthony M J Bull, Alexander BennettSee the full list of authors
16 January 2025
Vitamin D affects the risk of disease activity in multiple sclerosis Antonino Giordano, Ferdinando Clarelli, Béatrice Pignolet, Elisabetta Mascia, Melissa Sorosina, Kaalindi Misra, Laura Ferrè, Florence Bucciarelli, Ali Manouchehrinia, Lucia Moiola, Vittorio Martinelli, Maria A Rocca, Roland Liblau, Massimo Filippi, Federica Esposito
16 January 2025
Prevalence of autoimmune diseases in functional neurological disorder: influence of psychiatric comorbidities and biological sex Anna Joseph, Gaston Baslet, Mary A O’Neal, Ginger Polich, Irene Gonsalvez, Andrea N Christoforou, Barbara A Dworetzky, Primavera A Spagnolo
16 August 2024
Paternal exposure to antiseizure medications and offspring outcomes Torbjörn Tomson
16 December 2024
Prognosis prediction and immunotherapy optimisation for cryptogenic new-onset refractory status epilepticus Yoonhyuk Jang, Soo Hyun Ahn, Kyung-Il Park, Bum-Sup Jang, Han Sang Lee, Jae-Han Bae, Yoonkyung Lee, Jun-Sang Sunwoo, Jin-Sun Jun, Keun Tae Kim, Su Yee Mon, Ji Hye You, Tae-Joon Kim, Hyunsuk Shin, Dohyun HanSee the full list of authors
16 December 2024
Multiple metal exposures associate with higher amyotrophic lateral sclerosis risk and mortality independent of genetic risk and correlate to self-reported exposures: a case-control study Dae-Gyu Jang, John F Dou, Emily J Koubek, Samuel Teener, Lili Zhou, Kelly M Bakulski, Bhramar Mukherjee, Stuart A Batterman, Eva L Feldman, Stephen A Goutman
24 March 2025
Paternal exposure to antiseizure medications and offspring outcomes: a systematic review Eliza Honybun, Genevieve Rayner, Charles B Malpas, Terence J O'Brien, Frank J Vajda, Piero Perucca, Emilio Perucca
16 December 2024
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD Michael Benatar, Terry D Heiman-Patterson, Johnathan Cooper-Knock, Daniel Brickman, Kaitlin B Casaletto, Stephen A Goutman, Marco Vinceti, Laynie Dratch, Jalayne J Arias, Jean Swidler, Martin R Turner, Jeremy Shefner, Henk-Jan Westeneng, Leonard H van den Berg, Ammar Al-Chalabi
13 March 2025